(Total Views: 578)
Posted On: 08/20/2024 2:20:39 PM
Post# of 155122
Coya Therapeutics has low dose IL-2 phase 2 results in Alzheimer's to be presented end of October. Trial funding from Gates Foundation and Alzheimer's Association.
They have recently filed a patent application for low dose IL-2 and GLP-1 combo.
https://x.com/Microcapreturns/status/1825638322196111522
Hmm... I wonder if Mr. Collin is aware of leronlimab.
They have recently filed a patent application for low dose IL-2 and GLP-1 combo.
https://x.com/Microcapreturns/status/1825638322196111522
Hmm... I wonder if Mr. Collin is aware of leronlimab.
(2)
(0)
